Rocky Mountain MS Center

The Rocky Mountain MS Center at University of Colorado (RMMSC at CU) combines one of the most robust MS research programs in the nation with an innovative care model serving more than 4,200 patients a year.

The RMMSC at CU conducts basic science and translational research and has more than 30 clinical trials underway at any given time. Our physicians and scientists play a critical role in the development of current and everging MS therapies, as well as studies to determin the biological basis of the disease. Currently, this research is supported by the National Institutes of Health, the National Multiple Sclerosis Society and the Rocky Mountain MS Center.

Exciting studies underway include:

• • Role of B cell immunity in the pathogenesis of MS
  • Identification of the primary target of the humoral immune response in optic neuritis and MS
  • Examination of the humoral immune response in subacute sclerosing panencephalitis and MS
  • Identification of peptides/proteins specific for MS
  • Examination of the role of specific viruses in MS

Scientists at the MS research laboratories at the University of Colorado Denver are
national leaders in the effort to
find the cause and the cure for
multiple sclerosis.